Can Hormel Foods Offset Rising Input Costs With Pricing Actions?

Hormel Foods (HRL) reported 6% organic sales growth in Q3 FY25, but earnings lagged significantly due to approximately 400 basis points of raw material cost inflation, driven by sharp increases in pork and beef prices. The company is implementing targeted pricing actions to mitigate these pressures, with initial success in brands like Jennie-O, though broader margin benefits are expected to flow gradually, becoming more significant in Q1 FY26 due to retail pricing lag. Despite these efforts, HRL shares have underperformed, declining 15.8% in the past month, and the stock, rated a Zacks #5 (Strong Sell), trades at a premium P/E of 15.39 amidst downward EPS revisions.

Analysis

Hormel Foods (HRL) is facing a significant margin squeeze despite reporting strong top-line growth, with Q3 fiscal 2025 organic sales rising 6%. The primary headwind is severe commodity cost inflation, which created approximately 400 basis points of pressure, driven by year-over-year increases in pork bellies (+30%), pork cut-out (+10%), and pork trim (+20%), alongside beef prices near record highs. In response, the company is implementing targeted pricing actions, which have shown early success in restoring profitability for the Jennie-O brand. However, management has guided that the full benefit of these measures will be gradual due to the lag time in retail price adjustments, with a more meaningful impact not expected until Q1 of fiscal 2026. This challenging fundamental picture is reflected in the market's reaction: HRL shares have declined 15.8% in the past month, substantially underperforming the industry and broader market. Compounding the issue, consensus EPS estimates have been revised downward, and the stock carries a Zacks Rank #5 (Strong Sell), yet it trades at a premium forward P/E of 15.39 compared to the industry average of 11.65, indicating a potential valuation disconnect with its near-term outlook.

Key Decisions for Investors

• Given the significant margin compression from input costs and the guided delay in pricing benefits, investors should be cautious as profitability is likely to remain under pressure in the near term.
• The stock's premium valuation relative to its industry peers appears unjustified in light of its recent underperformance, downward earnings revisions, and a 'Strong Sell' rating, suggesting it may be vulnerable to further de-rating.
• Monitor upcoming earnings reports, particularly for Q4 and Q1 FY26, for evidence that pricing actions are successfully restoring margins without causing significant demand destruction, as this is the key catalyst for a potential change in the investment thesis.
• Consider the relative value presented by peers like Smithfield Foods (SFD) and Celsius Holdings (CELH), which the report highlights for their strong growth outlooks and positive analyst ratings, as potential alternatives to HRL's current fundamental challenges.